Description
In this webinar, we provide an overview of the recent advances in automated insulin delivery (AID) with Beta Bionics' iLet Bionic Pancreas and its adaptive closed-loop algorithms enabling fully autonomous insulin dosing with meal announcements. We will share the results of the pivotal trial and the most recent real-world data analysis. These advances highlight a paradigm shift in simplifying insulin management, thus expanding diabetes technology access to a broader population. We will also discuss the psychological adjustments some experience regarding transferring management to an algorithm.
We will consider the implications of technology advances on clinical practice and the DCES's expanded role in ongoing support of iLet users requiring behavioral education versus prescriptive therapy setting adjustments. The DCES can lead in improving the health of the populations they serve by expanding technology access to less traditional candidates. This will involve redefining success, individualizing the acceptable level of management balanced with the effort required for each person. Join us and be part of reimagining type 1 diabetes management!
Learning Objectives
After watching this webinar, you'll be able to:
-- Describe how Beta Bionics' iLet Bionic Pancreas is shifting insulin management paradigms with its adaptive closed-loop algorithms, enabling fully autonomous insulin dosing with meal announcements.
-- Discover the DCES's expanded role in ongoing support of iLet users requiring behavioral education versus prescriptive therapy setting adjustments.
-- Lead in improving the health of the population you serve by expanding technology access to less traditional candidates.
Agenda
1. Overview of the iLet Bionic Pancreas
2. The evidence
3. Managing individuals with T1D on iLet Bionic Pancreas
4. Key takeaways, resources, and Q&A
Sponsor
This device training webinar is sponsored by Beta Bionics.
Intended Audience
This activity is designed for diabetes
care and education specialists, including nurses, dietitians, pharmacists, pharmacy
technicians, physicians, PAs, social workers, and other health care providers
interested in staying up to date on current practices of care for people with
diabetes and other related conditions.
Disclaimer
This device training does not provide certification on the product discussed. There is no CE/CME credit for this activity.
Access
Period
You
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity expires (whichever comes
first).
Originally presented
on: 3/20/2025
Expiration
date: 3/20/2029
Resources:
iLet Bionic Pancreas Website: www.betabionics.com
iLet Bionic Pancreas Resources: www.betabionics.com/resources
iLet Bionic Pancreas Simulator App